Literature DB >> 12629189

Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

Bingbing Song1, Juan Carlos G Marvizón.   

Abstract

To evaluate the effect of peptidases on mu-opioid receptor (MOR) activation by endogenous opioids, we measured MOR-1 internalization in rat spinal cord slices. A mixture of inhibitors of aminopeptidases (amastatin), dipeptidyl carboxypeptidase (captopril), and neutral endopeptidase (phosphoramidon) dramatically increased the potencies of Leu-enkephalin and dynorphin A to produce MOR-1 internalization, and also enhanced the effects of Met-enkephalin and alpha-neoendorphin, but not endomorphins or beta-endorphin. The omission of any one inhibitor abolished Leu-enkephalin-induced internalization, indicating that all three peptidases degraded enkephalins. Amastatin preserved dynorphin A-induced internalization, and phosphoramidon, but not captopril, increased this effect, indicating that the effect of dynorphin A was prevented by aminopeptidases and neutral endopeptidase. Veratridine (30 microm) or 50 mm KCl produced MOR-1 internalization in the presence of peptidase inhibitors, but little or no internalization in their absence. These effects were attributed to opioid release, because they were abolished by the selective MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH(2)) and were Ca(2+) dependent. The effect of veratridine was protected by phosphoramidon plus amastatin or captopril, but not by amastatin plus captopril or by phosphoramidon alone, indicating that released opioids are primarily cleaved by neutral endopeptidase, with a lesser involvement of aminopeptidases and dipeptidyl carboxypeptidase. Therefore, because the potencies of endomorphin-1 and endomorphin-2 to elicit internalization were unaffected by peptidase inhibitors, the opioids released by veratridine were not endomorphins. Confocal microscopy revealed that MOR-1-expressing neurons were in close proximity to terminals containing opioids with enkephalin-like sequences. These findings indicate that peptidases prevent the activation of extrasynaptic MOR-1 in dorsal horn neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629189      PMCID: PMC2464295     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

1.  Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine.

Authors:  F Noble; S Turcaud; M C Fournié-Zaluski; B P Roques
Journal:  Eur J Pharmacol       Date:  1992-11-13       Impact factor: 4.432

2.  Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101.

Authors:  F Noble; P Coric; M C Fournié-Zaluski; B P Roques
Journal:  Eur J Pharmacol       Date:  1992-11-13       Impact factor: 4.432

3.  Spinal opioid analgesia: how critical is the regulation of substance P signaling?

Authors:  J A Trafton; C Abbadie; S Marchand; P W Mantyh; A I Basbaum
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

4.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord.

Authors:  U Arvidsson; M Riedl; S Chakrabarti; J H Lee; A H Nakano; R J Dado; H H Loh; P Y Law; M W Wessendorf; R Elde
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

Review 5.  The localization of classical transmitters and neuropeptides within neurons in laminae I-III of the mammalian spinal dorsal horn.

Authors:  A J Todd; R C Spike
Journal:  Prog Neurobiol       Date:  1993-11       Impact factor: 11.685

6.  Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.

Authors:  K Raynor; H Kong; Y Chen; K Yasuda; L Yu; G I Bell; T Reisine
Journal:  Mol Pharmacol       Date:  1994-02       Impact factor: 4.436

7.  Effect of some peptidase inhibitors on exogenous and endogenous opioid actions in guinea-pig ileum.

Authors:  M Ozaki; Y Miyamoto; S Kishioka; Y Masuda; H Yamamoto
Journal:  Biol Pharm Bull       Date:  1994-01       Impact factor: 2.233

8.  Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord.

Authors:  M Randić; M C Jiang; R Cerne
Journal:  J Neurosci       Date:  1993-12       Impact factor: 6.167

9.  Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, beta-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats.

Authors:  S Kishioka; Y Miyamoto; Y Fukunaga; S Nishida; H Yamamoto
Journal:  Jpn J Pharmacol       Date:  1994-11

10.  Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.

Authors:  S Tieku; N M Hooper
Journal:  Biochem Pharmacol       Date:  1992-11-03       Impact factor: 5.858

View more
  22 in total

1.  Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors.

Authors:  Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2007-05-08       Impact factor: 3.252

2.  Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.

Authors:  Lijun Lao; Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

3.  N-methyl-D-aspartate receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce mu-opioid receptor internalization in the rat spinal cord.

Authors:  B Song; J C G Marvizón
Journal:  Neuroscience       Date:  2005-10-03       Impact factor: 3.590

4.  μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Authors:  W Chen; J A McRoberts; J C G Marvizón
Journal:  Neuroscience       Date:  2014-02-26       Impact factor: 3.590

5.  Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.

Authors:  Juan Carlos Marvizon; Wenling Chen; Weisi Fu; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-08-02       Impact factor: 5.250

6.  Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization.

Authors:  W Chen; J C G Marvizón
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

7.  Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors.

Authors:  Wenling Chen; Bingbing Song; Juan Carlos G Marvizón
Journal:  Neuropharmacology       Date:  2008-02-10       Impact factor: 5.250

8.  Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.

Authors:  A Gupta; W Fujita; I Gomes; E Bobeck; L A Devi
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study.

Authors:  Juan Carlos G Marvizón; Wenling Chen; Niall Murphy
Journal:  J Comp Neurol       Date:  2009-11-01       Impact factor: 3.215

Review 10.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.